Phenotypic knockouts of selected metabolic pathways by targeting enzymes with camel-derived nanobodies (VHHs)

Metabolic Engineering

Volumn 30, Issue , 2015, Pages 40-48

  Jiménez, José I ^a,b   Fraile, Sofía ^a   Zafra, Olga ^a,c   de Lorenzo, Víctor ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c CSIC   (Spain)

Author keywords

Nanobodies; Networks; Nicotinic acid; NicX; Pseudomonas putida; Systems biology; VHH

Indexed keywords

CYTOLOGY; ENZYMES; ESCHERICHIA COLI; NETWORKS (CIRCUITS);

NANOBODIES; NICOTINIC ACID; NICX; PSEUDOMONAS PUTIDA; SYSTEMS BIOLOGY;

METABOLISM;

NANOBODY; NICOTINIC ACID; THIOREDOXIN; BACTERIAL PROTEIN; DIOXYGENASE;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; CAMEL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; ESCHERICHIA COLI; METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; PSEUDOMONAS PUTIDA; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; ENZYMOLOGY; GENETICS;

ESCHERICHIA COLI; NEGIBACTERIA; PSEUDOMONAS PUTIDA;

ANIMALS; BACTERIAL PROTEINS; CAMELS; DIOXYGENASES; ESCHERICHIA COLI; PSEUDOMONAS PUTIDA; SINGLE-DOMAIN ANTIBODIES;

EID: 84929333222     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2015.04.002     Document Type: Article

References (42)

1. Ausubel F.M., et al. Current Protocols in Molecular Biology 1994, John Wiley & Sons, N.Y.
2. Behrman E.J., Stanier R.Y. The bacterial oxidation of nicotinic acid. J. Biol. Chem. 1957, 228:923-945.
3. Conrad U., Sonnewald U. Antibody jabs for plant enzymes. Nat. Biotechnol. 2003, 21:35-36.
4. Cortez-Retamozo V., et al. Efficient cancer therapy with a nanobody-based conjugate. Cancer Res. 2004, 64:2853-2857.
5. De Genst E., et al. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4586-4591.
6. de Lorenzo V., Timmis K.N. Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol. 1994, 235:386-405.
7. Desai S.K., Gallivan J.P. Genetic screens and selections for small molecules based on a synthetic riboswitch that activates protein translation. J. Am. Chem. Soc. 2004, 126:13247-13254.
8. Els Conrath K., et al. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 2001, 276:7346-7350.
9. Fernández L.A. Prokaryotic expression of antibodies and affibodies. Curr. Opin. Biotechnol. 2004, 15:364-373.
10. Fraile S., et al. NanoPad: an integrated platform for bacterial production of camel nanobodies aimed at detecting environmental biomarkers. Proteomics 2013, 13:2766-2775.
11. Fujiwara K., et al. A systematic survey of in vivo obligate chaperonin-dependent substrates. EMBO J. 2010, 29:1552-1564.
12. Govaert J., et al. Dual beneficial effect of interloop disulfide bond for single domain antibody fragments. J. Biol. Chem. 2012, 13:1970-1979.
13. Hamers-Casterman C., et al. Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448.
14. Hawkins K.M., Smolke C.D. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat. Chem. Biol. 2008, 4:564-573.
15. Holtz W.J., Keasling J.D. Engineering static and dynamic control of synthetic pathways. Cell 2010, 140:19-23.
16. Jiménez J.I., et al. A preliminary crystallographic study of recombinant NicX, an Fe(2+)-dependent 2,5-dihydroxypyridine dioxygenase from Pseudomonas putida KT2440. Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 2010, 66:549-553.
17. Jiménez J.I., et al. Deciphering the genetic determinants for aerobic nicotinic acid degradation: the nic cluster from Pseudomonas putida KT2440. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11329-11334.
18. Jobling S.A., et al. Immunomodulation of enzyme function in plants by single-domain antibody fragments. Nat. Biotechnol. 2003, 21:77-80.
19. Jurado P., et al. Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. J. Mol. Biol. 2002, 320:1-10.
20. Jurado P., et al. Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin. J. Mol. Biol. 2006, 357:49-61.
21. 54-promoter Pu of the TOL plasmid. Mol. Microbiol. 2006, 60:1218-1227.
22. Keasling J. From yeast to alkaloids. Nat. Chem. Biol. 2008, 4:524-525.
23. Keasling J.D. Manufacturing molecules through metabolic engineering. Science 2010, 330:1355-1358.
24. Kerner M.J., et al. Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli. Cell 2005, 122:209-220.
25. Landgraf D., et al. Segregation of molecules at cell division reveals native protein localization. Nat. Methods 2012, 9:480-482.
26. Lo A.S.Y., et al. Intracellular antibodies (intrabodies) and their therapeutic potential. Handb. Exp. Pharmacol. 2008, 181:343-373.
27. Long C.P., Antoniewicz M.R. Metabolic flux analysis of Escherichia coli knockouts: lessons from the Keio collection and future outlook. Curr. Opin. Biotechnol. 2014, 28:127-133.
28. Man S., et al. Artificial trans-encoded small non-coding RNAs specifically silence the selected gene expression in bacteria. Nucleic Acids Res. 2011.
29. Miller J.H. A Short Course in Bacterial Genetics 1992, Cold Spring Harbor Laboratory Press, N.Y.
30. Na D., et al. Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat. Biotechnol. 2013, 31:170-174.
31. Nelson K.E., et al. Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ. Microbiol. 2002, 4:799-808.
32. Nicola A.V., et al. Co-translational folding of an alphavirus capsid protein in the cytosol of living cells. Nat. Cell Biol. 1999, 1:341-345.
33. Nikel P.I., et al. Biotechnological domestication of pseudomonads using synthetic biology. Nat. Rev. Microbiol. 2014, 12:368-379.
34. Nogales J., et al. Molecular characterization of the gallate dioxygenase from Pseudomonas putida KT2440. J. Biol. Chem. 2005, 280:35382-35390.
35. Saerens D., et al. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains. J. Mol. Biol. 2008, 377:478-488.
36. Saier M.H. Microcompartments and protein machines in prokaryotes. J. Mol. Microbiol Biotechnol. 2013, 23:243-269.
37. Sambrook Russell Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, New York. 3rd ed.
38. Schevchenko A., et al. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
39. Silva-Rocha R., et al. The Standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes. Nucleic Acids Res. 2013, 41:D666-D675.
40. Visintin M., et al. Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11723-11728.
41. Yoshida T., Nagasawa T. Enzymatic functionalization of aromatic N-heterocycles: hydroxylation and carboxylation. J. Biosci. Bioeng. 2000, 89:111-118.
42. Zafra O., et al. Monitoring biodegradative enzymes with nanobodies raised in Camelus dromedarius with mixtures of catabolic proteins. Environ. Microbiol. 2011, 13:960-974.